Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02427's Gross Margin % is ranked worse than 85.49% of 193
companies
in the Medical Diagnostics & Research industry
Industry Median: 51.31
vs HKSE:02427: 24.95
Guanze Medical Information Industry (Holding) Co had a gross margin of 15.45% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
Guanze Medical Information Industry (Holding) Co (HKSE:02427) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Guanze Medical Information Industry (Holding) Co had a gross margin of 15.45% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Guanze Medical Information Industry (Holding) Co Gross Margin % Related Terms
Guanze Medical Information Industry (Holding) Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guanze Medical Information Industry (Holding) Co Gross Margin % Chart
Guanze Medical Information Industry (Holding) Co Annual Data
HKSE:02427 vs TMO, DHR, IDXX: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Guanze Medical Information Industry (Holding) Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guanze Medical Information Industry (Holding) Co Gross Margin % vs Medical Diagnostics & Research Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Guanze Medical Information Industry (Holding) Co (HKSE:02427) has a Gross Margin % of 15.45% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Guanze Medical Information Industry (Holding) Co and its competitors. This is 57% below median its historical median of 35.86. Over the past decade, Guanze Medical Information Industry (Holding) Co's Gross Margin % has ranged from 24.95 to 54.72. According to the industry distribution chart, Guanze Medical Information Industry (Holding) Co ranks #165 out of 193 companies in the Medical Diagnostics & Research industry, placing it in the top 85.5%.
Is Guanze Medical Information Industry (Holding) Co's Gross Margin % too high?
Guanze Medical Information Industry (Holding) Co's current Gross Margin % of 15.45% is 57% below median its 10-year median of 35.86. Over the past 10 years, this metric has ranged from a low of 24.95 to a high of 54.72. The Medical Diagnostics & Research industry median Gross Margin % is 51.31. Guanze Medical Information Industry (Holding) Co's value of 15.45% is 69.9% below this industry median. Based on the distribution chart, Guanze Medical Information Industry (Holding) Co ranks #165 out of 193 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Guanze Medical Information Industry (Holding) Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guanze Medical Information Industry (Holding) Co's Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Guanze Medical Information Industry (Holding) Co ranks #165 out of 193 companies for Gross Margin %. This places Guanze Medical Information Industry (Holding) Co in the lower half of its industry. The industry median Gross Margin % is 51.31. Guanze Medical Information Industry (Holding) Co's value of 15.45% is 69.9% below this benchmark. Historically, Guanze Medical Information Industry (Holding) Co's own Gross Margin % has ranged from 24.95 to 54.72 over the past decade. While the company's 10-year median is 35.86 vs. the industry median of 51.31, Guanze Medical Information Industry (Holding) Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 51.31, based on 193 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guanze Medical Information Industry (Holding) Co's current Gross Margin % of 15.45% is 69.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Guanze Medical Information Industry (Holding) Co and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 51.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guanze Medical Information Industry (Holding) Co's current Gross Margin % is 15.45%, which is 57% below median its own 10-year median of 35.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guanze Medical Information Industry (Holding) Co stock overvalued right now?
Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co (HKSE:02427) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.28, compared to a current price of HK$2.80 — trading 900% above its estimated fair value. The current Gross Margin % is 15.45%, which is 57% below median its 10-year median of 35.86 and 69.9% below the Medical Diagnostics & Research industry median of 51.31. Guanze Medical Information Industry (Holding) Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Guanze Medical Information Industry (Holding) Co (HKSE:02427), the current Gross Margin % is 15.45% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guanze Medical Information Industry (Holding) Co (HKSE:02427) Overvalued in 2026?
Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co stock appears to be overvalued.
The current stock price of HK$2.80 is trading 900% above its estimated GF Value™ of HK$0.28.
GuruFocus considers Guanze Medical Information Industry (Holding) Co to be Significantly Overvalued.
Key valuation signals for HKSE:02427:
Gross Margin %: 15.45% (57% below median its 10-year median of 35.86)
GF Value™: HK$0.28 vs. price of HK$2.80 (900% above fair value)
Industry Position: 69.9% below the Medical Diagnostics & Research median (#165 of 193)
No single metric tells the full story. See the HKSE:02427 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guanze Medical Information Industry (Holding) Co Business Description
Guanze Medical Information Industry (Holding) Co Ltd is a medical imaging solutions provider, principally engaged in providing medical imaging film products and medical imaging cloud services in Shandong Province. The company generates the majority of its revenue from the PRC.
52GF Score
Get the complete analysis for HKSE:02427
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02427 has been successfully added to your 
